Localization techniques for guided surgical excision of non-palpable breast lesions

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 12, 2015, Pages

  Chan, Benjamin K Y ^a   Wiseberg Firtell, Jill A ^b   Jois, Ramesh H S ^a   Jensen, Katrin ^c   Audisio, Riccardo A ^a  

^a ST HELENS AND KNOWSLEY TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBENE; IODINE 123; RADIOACTIVE IODINE;

BENIGN NEOPLASM; BREAST CANCER; BREAST SURGERY; BREAST TUMOR; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; ECHOMAMMOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LUMPECTOMY; META ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; REVIEW; SURGICAL MARGIN; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR LOCALIZATION; WIRE GUIDED LOCALIZATION; BREAST NEOPLASMS; FEMALE; FIDUCIAL MARKER; PALPATION; PATHOLOGY; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; FIDUCIAL MARKERS; HUMANS; IODINE RADIOISOTOPES; PALPATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TUMOR BURDEN;

EID: 84963783572     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009206.pub2     Document Type: Review

References (46)

1. Gray RJ, Salud C, Nguyen K, Dauway E, Friedland J, Berman C, et al. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Annals of Surgical Oncology 2001;8(9):711-5.
2. Lovrics PJ, Goldsmith CH, Hodgson N, McCready D, Gohla G, Boylan C, et al. A multicentered, randomized, controlled trial comparing radioguided seed localization to standard wire localization for nonpalpable, invasive and in situ breast carcinomas. Annals of Surgical Oncology 2011;18(12):3407-14.
3. Mariscal Martínez A, Solà M, de Tudela AP, Julián JF, Fraile M, Vizcaya S, et al. Radioguided localization of nonpalpable breast cancer lesions: randomized comparison with wire localization in patients undergoing conservative surgery and sentinel node biopsy. American Journal of Roentgenology 2009;193(4):1001-9.
4. Medina-Franco H, Abarca-Pérez L, García-Alvarez MN, Ulloa-Gómez JL, Romero-Trejo C, Sepúlveda-Méndez J. Radioguided occult lesion localization (ROLL) versus wire-guided lumpectomy for non-palpable breast lesions: a randomized prospective evaluation. Journal of Surgical Oncology 2008;97(2):108-11.
5. Moreno M, Wiltgen JE, Bodanese B, Schmitt RL, Gutfilen B, da Fonseca LM. Radioguided breast surgery for occult lesion localization - correlation between two methods. Journal of Experimental & Clinical Cancer Research 2008;27:29.
6. Ocal K, Dag A, Turkmenoglu O, Gunay EC, Yucel E, Duce MN. Radioguided occult lesion localization versus wire-guided localization for non-palpable breast lesions: randomized controlled trial. Clinics (São Paulo) 2011;66(6):1003-7.
7. Postma EL, Verkooijen HM, van Esser S, Hobbelink MG, van der Schelling GP, Koelemij R, et al. Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial. Breast Cancer Research and Treatment 2012;136(2):469-78.
8. Rampaul RS, Bagnall M, Burrell H, Pinder SE, Evans AJ, Macmillan RD. Randomized clinical trial comparing radioisotope occult lesion localization and wire-guided excision for biopsy of occult breast lesions. The British Journal of Surgery 2004;91(12):1575-7.
9. Rahusen FD, Bremers AJ, Fabry HF, van Amerongen AH, Boom RP, Meijer S. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Annals of Surgical Oncology 2002;9(10):994-8.
10. Tafra L, Fine R, Whitworth P, Berry M, Woods J, Ekbom G, et al. Prospective randomized study comparing cryo-assisted and needle-wire localization of ultrasound-visible breast tumors. American Journal of Surgery 2006;192(4):462-70.
11. Tang J, Xie XM, Wang X, Xie ZM, He JH, Wu YP, et al. Radiocolloid in combination with methylene dye localization, rather than wire localization, is a preferred procedure for excisional biopsy of nonpalpable breast lesions. Annals of Surgical Oncology 2011;18(1):109-13.
12. A Randomized Study of Localization of Nonpalpable Breast Lesions - RSL vs WGL. Ongoing study January 2014.
13. Ahmed M, van Hemelrijck M, Douek M. Systematic review of radioguided versus wire-guided localization in the treatment of non-palpable breast cancers. Breast Cancer Research Treatment 2013;140(2):241-52.
14. Audisio RA, Nadeem R, Harris O, Desmond S, Thind R, Chagla LS. Radioguided occult lesion localisation (ROLL) is available in the UK for impalpable breast lesions. Annals of the Royal College of Surgeons of England 2005;87(2):92-5.
15. Bruce N, Pope D, Stanistreet D. Quantitative Methods for Health Research: a Practical Guide to Epidemiology and Statistics. 1st Edition. Chichester: Wiley-Interscience, 2008.
16. Wilcken N, Ghersi D, Brunswick C, Clarke M, Dinh P, Ganz P, et al. Cochrane Breast Cancer Group. In: the Cochrane Library, 2009, Issue 3. Chichester: Wiley-Blackwell. Updated quarterly. http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/BREASTCA/frame.html (accessed 16 December 2015).
17. De Cicco C, Pizzamiglio M, Trifirò G, Luini A, Ferrari M, Prisco G, et al. Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspects. The Quarterly Journal of Nuclear Medicine 2002;46(2):145-51.
18. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
19. Ernst MF, Roukema JA. Diagnosis of non-palpable breast cancer: a review. The Breast 2002;11(1):13-22.
20. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Annals of Oncology 2007;18(3):581-92.
21. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. The New England Journal of Medicine 2002;347(16):1233-41.
22. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
23. Hirsch JI, Banks WL Jr, Sullivan JS, Horsley JS 3rd. Effect of methylene blue on estrogen-receptor activity. Radiology 1989;171(1):105-7.
24. Hughes JH, Mason MC, Gray RJ, McLaughlin SA, Degnim AC, Fulmer JT, et al. A multi-site validation trial of radioactive seed localization as an alternative to wire localization. The Breast Journal 2008;14(2):153-7.
25. Jakub JW, Gray RJ, Degnim AC, Boughey JC, Gardner M, Cox CE. Current status of radioactive seed for localization of non palpable breast lesions. American Journal of Surgery 2010;199(4):522-8.
26. Lovrics PJ, Cornacchi SD, Vora R, Goldsmith CH, Kahnamoui K. Systematic review of radioguided surgery for non-palpable breast cancer. European Journal of Surgical Oncology 2011;37(5):388-97.
27. Luini A, Zurrida S, Galimberti V, Paganelli G. Radioguided surgery of occult breast lesions. European Journal of Cancer 1998;34(1):204-5.
28. Nadeem R, Chagla LS, Harris O, Desmond S, Thind R, Titterrell C, et al. Occult breast lesions: A comparison between radioguided occult lesion localisation (ROLL) vs. wire-guided lumpectomy (WGL). The Breast 2005;14(4):283-9.
29. Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Annals of Internal Medicine 1992;116(1):78-84.
30. Philips N, Coldman A. Comparison of nonbreast cancer incidence, survival and mortality between breast screening program participants and nonparticipants. International Journal of Cancer 2008;122(1):197-201.
31. Pleijhuis RG, Graafland M, de Vries J, Bart J, de Jong JS, van Dam GM. Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions. Annals of Surgical Oncology 2009;16(10):2717-30.
32. R Core Team. R: A Language and Environment for Statistical Computing. Version Version 3.2.2. Vienna: R Foundation for Statistical Computing, 14 August 2015.
33. Schwarzer G. R: Package 'meta'. Version Version 4.3-0 (02 July 2015). Vienna: R Foundation for Statistical Computing, 2015.
34. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
35. Rose A, Collins JP, Neerhut P, Bishop CV, Mann GB. Carbon localisation of impalpable breast lesions. The Breast 2003;12(4):264-9.
36. Rovera F, Frattini F, Marelli M, Corben AD, Vanoli C, Dionigi G, et al. Radio-guided occult lesion localization versus wire-guided localization in non-palpable breast lesions. International Journal of Surgery 2008;6 Suppl 1:S101-3.
37. Sajid MS, Parampalli U, Haider Z, Bonomi R. Comparison of radioguided occult lesion localization (ROLL) and wire localization for non-palpable breast cancers: a meta-analysis. Journal of Surgical Oncology 2012;105(8):852-8.
38. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
39. Schwartz GF, Veronesi U, Clough KB, Dixon JM, Fentiman IS, Heywang-Köbrunner SH, et al. Consensus conference on breast conservation. Journal of the American College of Surgeons 2006;203(2):198-207.
40. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glaziou P, et al. Chapter 12: Interpretingresults and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
41. Tromberg BJ, Pogue BW, Paulsen KD, Yodh AG, Boas DA, Cerussi AE. Assessing the future of diffuse optical imaging technologies for breast cancer management. Medical Physics 2008;35(6):2443-51.
42. The Independent UK Panel on Breast Cancer Screening. The Benefits and Harms of Breast Cancer Screening: An Independent Review. http://legacy.screening.nhs.uk/breastcancer (accessed 16 December 2015).
43. van der Ploeg IM, Hobbelink M, van den Bosch MA, Mali WP, Borel Rinkes IH, van Hillegersberg R. 'Radioguided occult lesion localisation' (ROLL) for non-palpable breast lesions: a review of the relevant literature. European Journal of Surgical Oncology 2008;34(1):1-5.
44. Van Esser S, Hobbelink M, Van der Ploeg IM, Mali WP, Van Diest PJ, Borel Rinkes IH, et al. Radio guided occult lesion localization (ROLL) for non-palpable invasive breast cancer. Journal of Surgical Oncology 2008;98(7):526-9.
45. Wilson M, Boggis CR, Mansel RE, Harland RN. Non-invasive ultrasound localization of impalpable breast lesions. Clinical Radiology 1993;47(5):337-8.
46. Chan BKY, Jois RHS, Wiseberg JA, Audisio RA. Localization techniques for guided surgical excision of non-palpable breast lesions. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD009206]